Quantamental Technologies LLC Alkermes Plc. Transaction History

Quantamental Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $238,070 - $284,730	10,851 New	10,851 $283,000
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $229,257 - $265,209	8,684 New	8,684 $259,000
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $188,024 - $305,792	-14,397 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $48,325 - $60,763	2,795 Added 24.09%	14,397 $294,000
Q3 2019 Nov 08, 2019	SELL	$19.51 - $24.28 $183,452 - $228,304	-9,403 Reduced 44.77%	11,602 $226,000
Q2 2019 Aug 12, 2019	BUY	$21.47 - $37.33 $228,827 - $397,863	10,658 Added 103.01%	21,005 $473,000
Q1 2019 Apr 29, 2019	BUY	$28.4 - $36.49 $159,324 - $204,708	5,610 Added 118.43%	10,347 $378,000
Q4 2018 Jan 28, 2019	BUY	$27.94 - $44.61 $132,351 - $211,317	4,737 New	4,737 $140,000

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.